Premium
Targeted Therapy for Breast Cancer Stem Cells by Liposomal Delivery of siRNA against Fibronectin EDB
Author(s) -
Sun Yujin,
Kim Hoe Suk,
Saw Phei Er,
Jon Sangyong,
Moon Woo Kyung
Publication year - 2015
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201500190
Subject(s) - cancer research , in vivo , gene knockdown , liposome , breast cancer , stem cell , medicine , cancer , chemistry , materials science , biology , nanotechnology , microbiology and biotechnology , apoptosis , biochemistry
Targeted therapy for breast cancer stem cell (BCSC) : A novel liposomal system (APT EDB ‐LS‐siRNA EDB ) that enables simultaneous targeting and knockdown of extra domain B of fibronectin (EDB‐FN) shows potent therapeutic efficacy in the BCSC‐derived tumors in vivo.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom